Pituitary volume in patients with panic disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 1, 2011, Pages 203-207

  Kartalci, Sukru ^a   Dogan, Metin ^a   Unal, Suheyla ^a   Ozcan, A Cemal ^a   Ozdemir, Serdal ^a   Atmaca, Murad ^b  

^a INONU UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Agoraphobia; HPA axis; Magnetic resonance imaging; Panic disorder; Pituitary gland volume

Indexed keywords

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PANIC; PITUITARY GLAND VOLUME; PSYCHOLOGIC ASSESSMENT;

ADULT; AGORAPHOBIA; ANALYSIS OF VARIANCE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY GLAND; SOMATOFORM DISORDERS; YOUNG ADULT;

EID: 78650943534     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.11.005     Document Type: Article

References (65)

1. Abelson J.L., Curtis G.C. Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 1996, 53:323-331.
2. Abelson J.L., Khan S., Liberzon I., Young E.A. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety 2007, 24:66-76.
3. Al-Haddad M.K., Sequeira R.P., Nayar U. Neurobiological correlates of panic disorder and agoraphobia. J Postgrad Med 2001, 47:55-61.
4. American Psychiatry Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA Press, Washington, DC, Author. 4th ed.
5. Atmaca M., Yildirim H., Ozler S., Koc M., Kara B., Sec S. Smaller pituitary volume in adult patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci 2009, 63:516-520.
6. Atmaca M., Yildirim H., Sec S., Kayali A. Pituitary volumes in hypochondriac patients. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:344-347.
7. Bailly D., Servant D., Dewailly D., Beuscart R., Racadot A., Fossati P., et al. Corticotropin releasing factor stimulation test in obsessive compulsive disorder. Biol Psychiatry 1994, 35:143-146.
8. Bandelow B. Assessing the efficacy of treatments for panic disorder and agoraphobia, II: the Panic and Agoraphobia Scale. Int Clin Psychopharmacol 1995, 10:73-81.
9. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., et al. A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 1981, 38:15-22.
10. Chakeres D.W., Curtin A., Ford G. Magnetic resonance imaging of pituitary and parasellar abnormalities. Radiol Clin North Am 1989, 27:265-281.
11. Coplan J.D., Goetz R., Klein D.F., Papp L.A., Fyer A.J., Liebowitz M.R., et al. Plasma cortisol concentrations preceding lactate-induced panic: psychological, biochemical, and physiological correlates. Arch Gen Psychiatry 1998, 55:130-136.
12. Çorapçioǧlu A., Aydemir Ö., Yildiz M., Köroǧlu E. DSM-IV Eksen I Bozukluklari (SCID-I) İçin Yapilandirilmiş Klinik Görüşme 1999, Klinik Versiyon, Hekimler Yayin Birliĝi, Ankara.
13. Coryell W., Noyes R. HPA axis disturbance and treatment outcome in panic disorder. Biol Psychiatry 1988, 24:762-766.
14. Coryell W., Noyes R., Schlechte J. The significance of HPA axis disturbance in panic disorder. Biol Psychiatry 1989, 25:989-1002.
15. Daniels D.L., Haughton V.M., Naidich T.P. Cranial and Spinal Magnetic Resonance Imaging an Atlas and Guide 1987, Raven Press, New York.
16. Del-Ben C.M., Graeff F.G. Panic disorder: is the PAG involved?. Neural Plast 2009, 2009:108-135.
17. Doraiswamy P.M., Krishnan K.R., Boyko O.B., Husain M.M., Figiel G.S., Palese V.J., et al. Pituitary abnormalities in eating disorders: further evidence from MRI studies. Prog Neuropsychopharmacol Biol Psychiatry 1991, 15:351-356.
18. Engel K., Bandelow B., Gruber O., Wedekind D. Neuroimaging in anxiety disorders. J Neural Transm 2009, 116:703-716.
19. Garcia-Leal C., Parente A.C., Del-Ben C.M., Guimarães F.S., Moreira A.C., Elias L.L., et al. Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking. Psychiatry Res 2005, 133:239-252.
20. Garcia-Leal C., Del-Ben C.M., Leal F.M., Graeff F.G., Guimarães F.S. Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation. J Psychopharmacol 2010, 24:683-694.
21. Garner B., Pariante C.M., Wood S.J., Velakoulis D., Phillips L., Soulsby B., et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 2005, 58:417-423.
22. Goldstein S., Halbreich U., Asnis G., Endicott J., Alvir J. The hypothalamic-pituitary-adrenal system in panic disorder. Am J Psychiatry 1987, 144:1320-1323.
23. Gonzalez J.G., Elizondo G., Saldivar D., Nanez H., Todd L.E., Villarreal J.Z. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988, 85:217-220.
24. Gorman J.M., Kent J.M., Sullivan G.M., Coplan J.D. Neuroanatomical hypothesis of panic disorder. Revised. Am J Psychiatry 2000, 157:493-505.
25. Graeff F.G., Del-Ben C.M. Neurobiology of panic disorder: from animal models to brain neuroimaging. Neurosci Biobehav Rev 2008, 32:1326-1335.
26. Hibbert G.A. Ideational components of anxiety: their origin and content. Br J Psychiatry 1984, 144:618-624.
27. Hobbs J.A., Shekhar A. Developmental aspects of panic and related anxiety disorders. Neuroembryology 2003, 2:72-80.
28. Holsboer F., von Bardeleben U., Buller R., Heuser I., Steiger A. Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res 1987, 16:80-88.
29. Jung M.H., Huh M.J., Kang D.H., Choi J.S., Jung W.H., Jang J.H., et al. Volumetric differences in the pituitary between drug-naïve and medicated male patients with obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:605-609.
30. Klerman G.L. Depression and panic anxiety: the effect of depressive comorbidity on response to drug treatment of patients with panic disorder and agoraphobia. J Psychiatr Res 1990, 24:27-41.
31. Krishnan K.R., France R.D., Pelton S., McCann U.D., Manepalli A.N., Davidson J.R. What does the dexamethasone suppression test identify?. Biol Psychiatry 1985, 20:957-964.
32. Krishnan K.R.R., Doraiswamy P.M., Lurie S.N., Figiel G.S., Husain M.M., Boyko O.B., et al. Pituitary size in depression. J Clin Endocrinol Metab 1991, 72:256-259.
33. Lammers C.H., Garcia-Borreguero D., Schmider J., Gotthardt U., Dettling M., Holsboer F., et al. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II. Biol Psychiatry 1995, 38:803-807.
34. MacMaster F.P., Kusumakar V. MRI study of the pituitary gland in adolescent depression. J Psychiatr Res 2004, 38:231-236.
35. MacMaster F.P., Russell A., Mirza Y., Keshavan M.S., Banerjee S.P., Bhandari R., et al. Pituitary volume in pediatric obsessive-compulsive disorder. Biol Psychiatry 2006, 59:252-257.
36. MacMaster F.P., Russell A., Mirza Y., Keshavan M.S., Taormina S.P., Bhandari R., et al. Pituitary volume in treatment-naïve pediatric major depressive disorder. Biol Psychiatry 2006, 60:862-866.
37. MacMaster F.P., Leslie R., Rosenberg D.R., Kusumakar V. Pituitary gland volume in adolescent and young adult bipolar and unipolar depression. Bipolar Disord 2008, 10:101-104.
38. Martin E.I., Ressler K.J., Binder E., Nemeroff C.B. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am 2009, 32:549-575.
39. Massana G., Serra-Grabulosa J.M., Salgado-Pineda P., Gastó C., Junqué C., Massana J., et al. Amygdalar atrophy in panic disorder patients detected by volume tric magnetic resonance imaging. Neuroimage 2003, 19:80-90.
40. Nemeroff C.B., Krishnan K.R., Reed D., Leder L., Beam C., Dunnik N.R. Adrenal gland enlargement in major depression. A computed tomographic study. Arch Gen Psychiatry 1992, 49:384-387.
41. Pariante C.M. Pituitary volume in psychosis: the first review of the evidence. J Psychopharmacol 2008, 22:76-81.
42. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., et al. Pituitary volume in psychosis. Br J Psychiatry 2004, 185:5-10.
43. Pariante C.M., Dazzan P., Danese A., Morgan K.D., Brudaglio F., Morgan C., et al. Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 2005, 30:1923-1931.
44. Petrowski K., Herold U., Joraschky P., Wittchen H.U., Kirschbaum C. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses. Psychoneuroendocrinology 2010, 35:414-421.
45. Risbrough V.B., Stein M.B. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav 2006, 50:550-561.
46. Roy-Byrne P.P., Uhde T.W., Post R.M., Gallucci W., Chrousos G.P., Gold P.W. The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 1986, 143:896-899.
47. Roy-Byrne P.P., Uhde T.W., Rubinow D.R., Post R.M. Reduced TSH and prolactin responses to TRH in patients with panic disorder. Am J Psychiatry 1986, 143:503-507.
48. Sassi R.B., Nicoletti M., Brambilla P., Harenski K., Mallinger A.G., Frank E., et al. Decreased pituitary volume in patients with bipolar disorder. Biol Psychiatry 2001, 50:271-280.
49. Schreiber W., Lauer C.J., Krumrey K., Holsboer F., Krieg J.C. Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder. Neuropsychopharmacology 1996, 15:7-15.
50. Sheline Y.I. 3DMRI studies of neuroanatomic changes in unipolarmajor depression: the role of stress and medical comorbility. Biol Psychiatry 2000, 48:791-800.
51. Sobanski T., Wagner G., Peikert G., Gruhn U., Schluttig K., Sauer H., et al. Temporal and right frontal lobe alterations in panic disorder: a quantitative volumetric and voxel-based morphometric MRI study. Psychol Med 2010, 8:1-8.
52. Spielberger C., Gorsuch R., Lushene R. STAI Manual for the State-trait Anxiety Inventory 1970, Consulting Psychologists Press, Palo Alto.
53. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev 2005, 4:141-194.
54. Takahashi T., Malhi G.S., Wood S.J., Walterfang M., Yücel M., Lorenzetti V., et al. Increased pituitary volume in patients with established bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1245-1249.
55. Takahashi T., Suzuki M., Velakoulis D., Lorenzetti V., Soulsby B., Zhou S.Y., et al. Increased pituitary volume in schizophrenia spectrum disorders. Schizophr Res 2009, 108:114-121.
56. Takano K., Utsunomiya H., Ono H., Ohfu M., Okazaki M. Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. AJNR Am J Neuroradiol 1999, 20:312-315.
57. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain 1988, Thieme-Stratton, New York.
58. Thomas L.A., De Bellis M.D. Pituitary volumes in pediatric maltreatment-related posttraumatic stress disorder. Biol Psychiatry 2004, 55:752-758.
59. Tukel R., Kora K., Hekim N., Oguz H., Alagol F. Thyrotropin stimulating hormone response to thyrotropin releasing hormone in patients with panic disorder. Psychoneuroendocrinology 1999, 24:155-160.
60. Uchida R.R., Del-Ben C.M., Busatto G.F., Duran F.L., Guimarães F.S., Crippa J.A., et al. Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Res 2008, 163:21-29.
61. Volsan O., Berzewski H. Baseline plasma cortisol and dexamethasone test in unselected psychiatric inpatients. Psychopathology 1985, 18:186-197.
62. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 2008, 4:189-216.
63. Westberg P., Modigh K., Lisjo P., Eriksson E. Higher postdexamethasone serum cortisol levels in agoraphobic than in nonagoraphobic panic disorder patients. Biol Psychiatry 1991, 30:247-256.
64. Woods S.W., Charney D.S., McPherson C.A., Gradman A.H., Heninger G.R. Situational panic attacks: behavioral, physiologic, and biochemical characterization. Arch Gen Psychiatry 1987, 44:365-375.
65. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., Akil H. Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 2003, 60:24-28.